{"transactions":[{"id":915798,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T13:00:21.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":32655,"source":{"system":"sec-edgar","filing":"0001683168-26-000811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826000811/ownership.xml","form_type":"4"}},{"id":1040147,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:29:41.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":14700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":16055,"source":{"system":"sec-edgar","filing":"0001683168-25-006958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006958/ownership.xml","form_type":"4"}},{"id":1407443,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-13T18:59:52.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001683168-24-006375","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824006375/ownership.xml","form_type":"4"}},{"id":1998893,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:25:15.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":3197,"source":{"system":"sec-edgar","filing":"0001209191-23-011937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123011937/doc4.xml","form_type":"4"}},{"id":2391334,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:08:38.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20364,"source":{"system":"sec-edgar","filing":"0001209191-22-010396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010396/doc4.xml","form_type":"4"}},{"id":2811650,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:25.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":10364,"source":{"system":"sec-edgar","filing":"0001209191-21-017574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017574/doc4.xml","form_type":"4"}},{"id":3653250,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-02-16T02:11:51.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-19-010830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119010830/doc4.xml","form_type":"4"}},{"id":3852767,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-04T01:36:22.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-045460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919118045460/doc4.xml","form_type":"4"}},{"id":4289518,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-08T01:13:13.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date."}],"balance_after":3500,"derivative":{"exercise_price":0.5429,"expiration_date":"2027-06-06","underlying":"Common stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-17-038449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919117038449/doc4.xml","form_type":"4"}}]}